AI Article Synopsis
- NSCLC is a common type of lung cancer, and this study investigated how LINC00518 and miR216b-5p affect tumor growth and cell proliferation in NSCLC.
- The researchers used various assays and animal models to assess the impact of manipulating these molecules on NSCLC cell behavior, particularly focusing on A549 cells.
- Their findings reveal that inhibiting LINC00518 can reduce the growth and spread of NSCLC, but this effect can be countered by lowering miR216b-5p levels, suggesting a complex interaction between these two factors in cancer progression.
Article Abstract
Introduction: Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases, and effective treatment for this disease is still lacking. This study aimed to explore the potential role of LINC00518 and miR216b-5p on cell proliferation and tumor growth in NSCLC.
Methods: The expression of LINC00518, miR216b-5p, MMP7, and MMP9 in NSCLC cell lines was determined by RT-qPCR analysis, which was also used to confirm the transfection effects. After transfection, proliferation, clone-formation ability, migration, and invasion of NSCLC cells were detected by CCK8, clone-formation, wound-healing, and transwell assays, respectively. Western blot analysis was used to detect the expression of MMP7, MMP9, Ki67, and PCNA. A xenograft model was constructed by subcutaneous injection of transfected NSCLC cells into nude mice.
Results: The results indicated that LINC00518 expression was increased and miR216b-5p expression decreased in NSCLC cell lines, and A549 cells were chosen for the next experiments. LINC00518 interference inhibited proliferation, invasion, and migration of A549 cells, together with the progression of NSCLC in vivo. In addition, LINC00518 directly targeted miR216b-5p. Downregulation of miR216b-5p weakened the inhibitory effect of LINC00518 interference on proliferation, invasion, and migration of A549 cells, as well as progression of NSCLC in vivo.
Discussion: In conclusion, LINC00518 interference inhibits NSCLC, which is partially reversed by downregulation of miR216b-5p expression.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646473 | PMC |
| http://dx.doi.org/10.2147/CMAR.S270087 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LINC00518 Interference Inhibits Non-Small Cell Lung Cancer by Upregulating miR216b-5p Expression.
Cancer Manag Res
November 2020
Department of Cardiothoracic Surgery, Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University, Suzhou, Jiangsu 215153, China.
Article Synopsis
- NSCLC is a common type of lung cancer, and this study investigated how LINC00518 and miR216b-5p affect tumor growth and cell proliferation in NSCLC.
- The researchers used various assays and animal models to assess the impact of manipulating these molecules on NSCLC cell behavior, particularly focusing on A549 cells.
- Their findings reveal that inhibiting LINC00518 can reduce the growth and spread of NSCLC, but this effect can be countered by lowering miR216b-5p levels, suggesting a complex interaction between these two factors in cancer progression.
Knockdown of Linc00515 Inhibits Multiple Myeloma Autophagy and Chemoresistance by Upregulating miR-140-5p and Downregulating ATG14.
Cell Physiol Biochem
September 2018
Department of Cardiovascular Medicine, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Background/aims: The purpose of our experiments was to investigate the targeting relationship of linc00515, miR-140-5p and ATG14 and to explore the roles of linc00515, miR-140-5p and ATG14 in autophagy and chemoresistance of melphalan-resistant multiple myeloma cells.
Methods: Plasmids that could interfere with the expression of linc00515 and ATG14 were loaded into myeloma cells, which were cultured with melphalan. MTT assay and flow cytometry analysis were utilized to investigate the effect of linc00515, miR-140-5p and ATG14 on the resistance of myeloma cells.
Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
Cell Physiol Biochem
September 2018
Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, China.
Background/aims: Long non-coding RNAs (LncRNAs) have been validated to be pivotal mediators in multidrug resistance (MDR) of various cancers. This study aims to explore the roles and molecular mechanisms of linc00518 implicated in chemoresistance in breast cancer.
Methods: Expressions of linc00518, miR-199a and MRP1 were evaluated by RT-qPCR or western blot.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!